Serena Williams Sparks Debate with Super Bowl Ad as Holger Rune Defends Her Health Journey

Serena Williams Sparks Debate with Super Bowl Ad as Holger Rune Defends Her Health Journey

Jaceline
Jaceline
Published: Feb 09, 2026

Serena Williams made headlines during Super Bowl LX with a candid endorsement of GLP-1 medication, sharing her personal health achievements. While the ad drew mixed reactions online, ATP star Holger Rune praised her openness and emphasized the medical oversight involved.

Super Bowl LX offered more than football excitement; it became a platform for Serena Williams to share a highly personal health journey. The tennis legend returned to headlines not for a court comeback but for a partnership with Ro, a GLP-1 provider. In the commercial, Williams revealed she had lost 34 pounds using the program and felt “strong, energized, and healthy.” The connection is further personal, with her husband, Reddit co-founder Alexis Ohanian, serving on Ro’s board.

The ad immediately sparked conversation online. Some fans questioned the message of a sports icon promoting weight-loss medication, particularly given the rising and sometimes controversial use of GLP-1 drugs like Ozempic. Social media voices expressed concern over the potential conflict between athletic role models and weight management products, highlighting the broader debate around health, image, and influence.

Amid the backlash, ATP rising star Holger Rune defended Williams. The 22-year-old Dane emphasized that seeking help for health challenges should not be shamed. “Being overweight carries health risks, like alcohol. Seeking help to overcome personal challenges is always the right thing to do,” he wrote on X. Rune praised Williams’ transparency and noted that GLP-1 medications require doctor evaluation and prescription. He added, “It is the doctors who decide if you are suited for this. We must trust medical professionals.”

Williams’ journey with Ro reportedly provided tangible health benefits, including reduced knee stress, more stable blood sugar, and lower cholesterol. These outcomes are particularly relevant as speculation grows about her potential return to professional tennis. The ITIA recently confirmed that Williams is eligible to compete again from February 22.

Importantly, GLP-1 medications are not banned by WADA but are monitored for potential misuse. This ensures Williams’ use complies with current sporting regulations, reinforcing that her public endorsement aligns with both health and professional standards.

As the conversation continues, Williams’ Super Bowl appearance underscores a complex intersection of health, sport, and public perception. Her candid approach, defended by peers like Rune, highlights the evolving discussion around athlete wellness and transparency.